Amy Kang
8PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jun 19, 2024
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.Kathryn Cardoza, Amy Kang, Brendan Smyth
|May 10, 2023
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials.Amy Kang, Brendan Smyth, Brendon L Neuen
|Jul 08, 2021
Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure: A Randomized Controlled Trial.Amy Kang, Ria Arnold, Martin Gallagher
|Oct 04, 2020
Risk factors for incident kidney disease in older adults: an Australian prospective population-based study.Amy Kang, Louisa Sukkar, Carinna Hockham
|Apr 15, 2020
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study.Celine Foote, Carinna Hockham, Louisa Sukkar
Pageof 2
Frequent Collaborators
3 joint publications
Brendan Smyth
2 joint publications
Marilina Antonelou
2 joint publications
Nishkantha Arulkumaran
2 joint publications
Frederick W K Tam
2 joint publications
Charles D Pusey
2 joint publications
Louisa Sukkar
2 joint publications
Rajiv Agarwal
2 joint publications
Clare Arnott
2 joint publications
Brendon L Neuen
2 joint publications
Meg Jardine
